HomeInsightsStock Comparison

Samrat Pharmachem Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Samrat Pharmachem Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Samrat Pharmachem Ltd is ₹ 338.7 as of 01 Aug 15:30.
  • The P/E Ratio of Samrat Pharmachem Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 38.1 on March 2025 . This represents a CAGR of 9.18% over 6 years.
  • The Market Cap of Samrat Pharmachem Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 416392 crore on March 2025 . This represents a CAGR of 30.45% over 6 years.
  • The revenue of Samrat Pharmachem Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sun Pharmaceutical Industries Ltd for the Jun '25 is ₹ 14315 crore as compare to the Mar '25 revenue of ₹ 13571 crore. This represent the growth of 5.48%.
  • The ebitda of Samrat Pharmachem Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sun Pharmaceutical Industries Ltd for the Jun '25 is ₹ 3948 crore as compare to the Mar '25 ebitda of ₹ 3967 crore. This represent the decline of -0.48%.
  • The net profit of Samrat Pharmachem Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2302 crore over 9 quarters. This represents a CAGR of 6.16% .
  • The Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 89.64 % on March 2025 . This represents a CAGR of 20.09% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Samrat Pharmachem Ltd

  • Samrat Pharmachem Limited was incorporated on June 16, 1992.
  • The Company's principal activities are manufacturing and selling chemicals. The Company floated a new 100% subsidiary company during the year 2003-04 named as Samrat Remedies Limited to carry on activities of Manufacturing of Pharmaceutical Bulk Drugs & Chemicals.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Samrat Pharmachem Ltd News Hub

News

Samrat Pharmachem to convene board meeting

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 13 Augus...

Read more

24 Jun 2025 09:54

News

Samrat Pharmachem AGM scheduled

Samrat Pharmachem announced that the 33th Annual General Meeting(AGM) of the company will ...

Read more

07 Jun 2025 17:20

News

Board of Samrat Pharmachem recommends final dividend

Samrat Pharmachem announced that the Board of Directors of the Company at its meeting held...

Read more

31 May 2025 12:04

News

Samrat Pharmachem to table results

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

27 Mar 2025 09:23

News

Samrat Pharmachem to declare Quarterly Result

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 Febru...

Read more

31 Dec 2024 19:58

News

Samrat Pharmachem announces board meeting date

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

28 Sep 2024 10:13

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharma drops after Q1 PAT slips 20% YoY to Rs 2,279 cr

The drop in profit was primarily due to a one-time exceptional charge of Rs 818 crore duri...

Read more

31 Jul 2025 15:46

News

Sun Pharmaceutical Industries Ltd spurts 0.66%, up for five straight sessions

Sun Pharmaceutical Industries Ltd rose for a fifth straight session today. The stock is qu...

Read more

29 Jul 2025 13:00

News

Sun Pharma announces top-line results of tildrakizumab 100 mg Phase 3 studies

Sun Pharmaceutical Industries announced top-line results from two Phase 3 clinical studies...

Read more

21 Jul 2025 09:05

News

Sun Pharmaceutical Industries Ltd spurts 2.56%, rises for third straight session

Sun Pharmaceutical Industries Ltd rose for a third straight session today. The stock is qu...

Read more

15 Jul 2025 13:05

News

Sun Pharma launches Leqselvi in US; settles litigation with Incyte Corp

The drug is indicated for the treatment of alopecia areata ' a condition in which the immu...

Read more

15 Jul 2025 15:41

News

Sun Pharmaceutical Industries launches LEQSELVI' (deuruxolitinib) 8 mg tablets in United States

Sun Pharmaceutical Industries announced LEQSELVI' (deuruxolitinib) 8 mg tablets is now ava...

Read more

14 Jul 2025 16:48

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Samrat Pharmachem Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Samrat Pharmachem Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Samrat Pharmachem Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Samrat Pharmachem Ltd is 104 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 390,863 Cr

What are the key factors driving the stock performance of Samrat Pharmachem Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Samrat Pharmachem Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Samrat Pharmachem Ltd and Sun Pharmaceutical Industries Ltd?

As of August 2, 2025, the Samrat Pharmachem Ltd stock price is INR ₹338.7. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1629.05.

How do dividend payouts of Samrat Pharmachem Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Samrat Pharmachem Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions